 |
Dr. Don Rix, Chairman of the Board
Dr. Rix is the founder and Chairman of MDS Metro Laboratory Services, which was sold to OMERS for $1.4 billion in 2007. Dr. Rix received the Order of Canada in 2007 for his contributions to the life science industry. |
| |
|
 |
Frank Holler, CEO and Partner
Frank Holler is an active investor and successful entrepreneur. He previously served as President & CEO of Xenon Pharmaceuticals Inc.; President & CEO of ID Biomedical Corporation; and as a founding director of Angiotech Pharmaceuticals. |
| |
|
 |
Jim Heppell, President and Partner
Jim Heppell has acted as a director or officer of, or advisor to, approximately one third of all life science companies spun out of BC universities. He is a co-founder and Fund Manager of the Advantage Life Science Fund I, the best performing retail fund in Canada over the last five years. |
| |
|
 |
David Raffa, COO and Partner
David Raffa is the former Chairman of ActiveState Corporation and co-founder of Amorfix Life Sciences. He is a mergers and acquisitions specialist. |
| |
|
 |
Tanner Philp, CFO and Partner
Tanner Philp is a director or officer of, or advisor to, early stage technology companies with experience in financings and mergers and acquisitions and is also the recipient of the 2007 BC Chartered Accountant Early achievement Award. |
| |
|
 |
Ray Matthews, Vice President of Sales & Marketing and Partner
Ray Matthews leads Advantage's fund raising efforts. He was co-founder of the Advantage Life Science Fund I, the best performing retain fund in Canada over the last five years. |
